Fundacion Dexeus
Clinical trials sponsored by Fundacion Dexeus, explained in plain language.
-
Weight-Loss drug may boost IVF success in overweight women
Disease control Recruiting nowThis study tests whether taking semaglutide (a weight-loss medication) for 12 weeks before starting IVF can improve the quality of embryos in women who are overweight or obese. About 62 women aged 38 or younger with a BMI between 27 and 40 will be randomly assigned to receive sem…
Phase: PHASE4 • Sponsor: Fundacion Dexeus • Aim: Disease control
Last updated May 17, 2026 07:50 UTC
-
AI takes on fertility doctors in IVF trigger showdown
Knowledge-focused Recruiting nowThis study compares an AI system to doctors for deciding the optimal day to trigger ovulation in IVF. About 644 women undergoing ovarian stimulation will be randomly assigned to AI-guided or doctor-led monitoring. The goal is to see if the AI can achieve similar results in the nu…
Phase: NA • Sponsor: Fundacion Dexeus • Aim: Knowledge-focused
Last updated May 17, 2026 07:49 UTC